Skip to Content

Vaccines, Volume 10, Issue 7

2022 July - 183 articles

Cover Story: The many intricacies of Pseudomonas aeruginosa infections and their pathogenesis have rendered over 50 years of vaccine research unsuccessful. Complex opportunistic and nosocomial infections cause significant disease burden for patients and healthcare systems. With the increasingly frequent acquisition of resistant infections, and the gradual ineffectiveness of current treatments, the development of a preventative vaccine is becoming increasingly vital. Here, we provide an up-to-date review of the extensive history of vaccine development against P. aeruginosa. We discuss important progress in the preclinical research on novel antigen discovery, adjuvant use, and, furthermore, vaccine delivery systems that aims to develop a more efficacious vaccine. View this paper
  • Issues are regarded as officially published after their release is announced to the table of contents alert mailing list .
  • You may sign up for email alerts to receive table of contents of newly released issues.
  • PDF is the official format for papers published in both, html and pdf forms. To view the papers in pdf format, click on the "PDF Full-text" link, and use the free Adobe Reader to open them.

Articles (183)

  • Communication
  • Open Access
4 Citations
2,615 Views
8 Pages

Patients with Chronic Lymphocytic Leukemia Have a Very High Risk of Ineffective Response to the BNT162b2 Vaccine

  • Andrea Galitzia,
  • Luca Barabino,
  • Roberta Murru,
  • Giovanni Caocci,
  • Marianna Greco,
  • Giancarlo Angioni,
  • Olga Mulas,
  • Sara Oppi,
  • Stefania Massidda and
  • Giorgio La Nasa
  • + 1 author

21 July 2022

Patients with CLL have high rates of either severe disease or death from COVID-19 and a low response rate after COVID-19 vaccination has been reported. We conducted a single-center study with the main objective to evaluate the immunogenicity of the B...

  • Article
  • Open Access
15 Citations
5,097 Views
12 Pages

Enabling Factors, Barriers, and Perceptions of Pneumococcal Vaccination Strategy Implementation: A Qualitative Study

  • Junjie Huang,
  • Fung-Yu Mak,
  • Yuet-Yan Wong,
  • Samantha Ko,
  • Marc K. C. Chong,
  • Zixin Wang,
  • Kam-Lun Hon,
  • Eliza L. Y. Wong,
  • Eng-Kiong Yeoh and
  • Martin C. S. Wong

21 July 2022

Invasive pneumococcal disease (IPD) is a leading cause of disability and mortality worldwide, particularly in the elderly population. With the implementation of the Government Vaccination Programme (GVP) and the Vaccination Subsidy Scheme (VSS), enab...

  • Article
  • Open Access
5 Citations
4,024 Views
11 Pages

Characterization of the Antibody and Interferon-Gamma Release Response after a Second COVID-19 Booster Vaccination

  • Katharina Grikscheit,
  • Holger F. Rabenau,
  • Zahra Ghodratian,
  • Marek Widera,
  • Alexander Wilhelm,
  • Tuna Toptan Grabmair,
  • Sebastian Hoehl,
  • Emily Layer,
  • Fabian Helfritz and
  • Sandra Ciesek

21 July 2022

The emergence of SARS-CoV-2 Omicron subvariants prompted countries to call for accelerated booster vaccinations to limit disease and transmission. Here, we characterized correlates of protection over time after the second booster or after Omicron BA....

  • Article
  • Open Access
13 Citations
3,021 Views
14 Pages

21 July 2022

Clear cell renal cell carcinoma (ccRCC) is the most common type of renal carcinoma. It is particularly important to accurately judge the prognosis of patients. Since most tumor prediction models depend on the specific expression level of related gene...

  • Article
  • Open Access
5 Citations
4,006 Views
14 Pages

High SARS-CoV-2 Seroprevalence and Rapid Neutralizing Antibody Decline among Agricultural Workers in Rural Guatemala, June 2020–March 2021

  • Chelsea Iwamoto,
  • Kelsey E. Lesteberg,
  • Molly M. Lamb,
  • Diva M. Calvimontes,
  • Kejun Guo,
  • Bradley S. Barrett,
  • Kaylee L. Mickens,
  • Lindsey M. Duca,
  • Jose Monzon and
  • Daniel Olson
  • + 14 authors

21 July 2022

Essential agricultural workers work under occupational conditions that may increase the risk of SARS-CoV-2 exposure and transmission. Data from an agricultural worker cohort in Guatemala, and anti-SARS-CoV-2 nucleocapsid IgG (anti-N IgG) testing were...

  • Article
  • Open Access
15 Citations
3,724 Views
10 Pages

Vaccination Intention against COVID-19 among the Unvaccinated in Jordan during the Early Phase of the Vaccination Drive: A Cross-Sectional Survey

  • Ilias Mahmud,
  • Mahmudul Hassan Al Imam,
  • Divya Vinnakota,
  • Khalid A. Kheirallah,
  • Mahmoud F. Jaber,
  • Adil Abalkhail,
  • Ibrahim Alasqah,
  • Thamer Alslamah and
  • Russell Kabir

21 July 2022

Objective: This study assessed the intention and predictors of accepting the corona virus disease 2019 (COVID-19) vaccine in Jordan. Method: A national-level online survey was conducted among adults (≥18 years) in Jordan between June and September...

  • Article
  • Open Access
10 Citations
3,127 Views
11 Pages

Behind the Scenes of COVID-19 Vaccine Hesitancy: Psychological Predictors in an Italian Community Sample

  • Sofia Tagini,
  • Agostino Brugnera,
  • Roberta Ferrucci,
  • Alberto Priori,
  • Angelo Compare,
  • Laura Parolin,
  • Gabriella Pravettoni,
  • Vincenzo Silani and
  • Barbara Poletti

21 July 2022

Psychological variables may be crucial in favoring or discouraging health-related behaviors, including vaccine acceptance. This study aimed to extend the previous literature by outlining the psychological profile associated with COVID-19 vaccine hesi...

  • Article
  • Open Access
5 Citations
2,526 Views
12 Pages

Influenza Vaccination Coverage among Multiple Sclerosis Patients: Evolution over Time and Associated Factors

  • Ignacio Hernández-García,
  • Moisés Garcés-Redondo,
  • Joana Rodríguez-Montolio,
  • Irantzu Bengoa-Urrengoechea,
  • Judit Espinosa-Rueda,
  • Carlos Aibar-Remón and
  • Vaccine Working Group

21 July 2022

Our objective was to determine the influenza vaccination rate in a Spanish cohort of multiple sclerosis (MS) patients. A retrospective cohort study was carried out. Patients who attended the MS unit of the Lozano Blesa Hospital of Zaragoza between Ja...

  • Review
  • Open Access
17 Citations
6,473 Views
13 Pages

Past, Present and Future of Bacillus Calmette-Guérin Vaccine Use in China

  • Junli Li,
  • Jinbiao Lu,
  • Guozhi Wang,
  • Aihua Zhao and
  • Miao Xu

20 July 2022

The BCG vaccine is prepared from a weakened strain of Mycobacterium bovis (M. bovis), a bacterium closely related to Mycobacterium tuberculosis (MTB), which causes tuberculosis (TB). The vaccine was developed over 13 years, from 1908 to 1921, in the...

  • Article
  • Open Access
8 Citations
2,556 Views
8 Pages

20 July 2022

Background: Human papillomavirus (HPV) vaccinations are rare among Polish children, and the reasons are scant. The objective was to evaluate the knowledge, attitude and awareness of parents about HPV vaccination to investigate reasons for low HPV vac...

  • Article
  • Open Access
18 Citations
3,809 Views
14 Pages

COVID-19 Vaccine for Children: Vaccination Willingness of Parents and Its Associated Factors—A Network Analysis

  • Julia Barbara Krakowczyk,
  • Alexander Bäuerle,
  • Lars Pape,
  • Theodor Kaup,
  • Laura Nulle,
  • Martin Teufel and
  • Eva-Maria Skoda

20 July 2022

Different COVID-19 vaccines have been approved for underage children, so parents and caregivers currently face the decision of whether to vaccinate their children against COVID-19 or not. Due to the rather moderate vaccine acceptance among parents ac...

  • Article
  • Open Access
20 Citations
9,708 Views
20 Pages

Persistent Health Issues, Adverse Events, and Effectiveness of Vaccines during the Second Wave of COVID-19: A Cohort Study from a Tertiary Hospital in North India

  • Upinder Kaur,
  • Sapna Bala,
  • Aditi Joshi,
  • Noti Taruni Srija Reddy,
  • Chetan Japur,
  • Mayank Chauhan,
  • Nikitha Pedapanga,
  • Shubham Kumar,
  • Anurup Mukherjee and
  • Sankha Shubhra Chakrabarti
  • + 13 authors

20 July 2022

Background There is paucity of real-world data on COVID-19 vaccine effectiveness from cohort designs. Variable vaccine performance has been observed in test-negative case-control designs. There is also scarce real-world data of health issues in indiv...

  • Article
  • Open Access
6 Citations
2,441 Views
7 Pages

Body Mass Index and Antibody Persistence after Measles, Mumps, Rubella and Hepatitis B Vaccinations

  • Marco Fonzo,
  • Annamaria Nicolli,
  • Stefano Maso,
  • Lorenzo Carrer,
  • Andrea Trevisan and
  • Chiara Bertoncello

20 July 2022

Overweight and obesity may cause a reduced response to vaccination. The purpose of the present research was to study the relationship between current body mass index (BMI) and antibody persistence after vaccination against measles, mumps, and rubella...

  • Article
  • Open Access
12 Citations
4,053 Views
13 Pages

Trends in Varicella Burden of Disease Following Introduction of Routine Childhood Varicella Vaccination in Argentina: A 12-Year Time Series Analysis

  • Norberto Giglio,
  • Pieralessandro Lasalvia,
  • Manjiri Pawaskar,
  • Cintia I. Parellada,
  • Yaneth Gil Rojas,
  • Paula Micone,
  • Virginia V. Babic and
  • Silvina E. Neyro

20 July 2022

One-dose universal varicella vaccination (UVV) was introduced in the Argentinian National Immunization Program in July 2015. This study examined the impact of one-dose UVV on varicella incidence and mortality in Argentina. Incidence and mortality dat...

  • Article
  • Open Access
5 Citations
2,836 Views
11 Pages

Human Coronavirus Spike Protein Based Multi-Epitope Vaccine against COVID-19 and Potential Future Zoonotic Coronaviruses by Using Immunoinformatic Approaches

  • Zulqarnain Baloch,
  • Aqsa Ikram,
  • Saba Shamim,
  • Ayesha Obaid,
  • Faryal Mehwish Awan,
  • Anam Naz,
  • Bisma Rauff,
  • Khadija Gilani and
  • Javed Anver Qureshi

19 July 2022

Zoonotic coronaviruses (CoV) have emerged twice and have caused severe respiratory diseases in humans. Due to the frequent outbreaks of different human coronaviruses (HCoVs), the development of a pan-HCoV vaccine is of great importance. Various conse...

  • Article
  • Open Access
12 Citations
3,493 Views
13 Pages

Vaccination with Omicron Inactivated Vaccine in Pre-vaccinated Mice Protects against SARS-CoV-2 Prototype and Omicron Variants

  • Yuntao Zhang,
  • Wenjie Tan,
  • Zhiyong Lou,
  • Yuxiu Zhao,
  • Jin Zhang,
  • Hongyang Liang,
  • Na Li,
  • Xiujuan Zhu,
  • Ling Ding and
  • Xiaoming Yang
  • + 20 authors

19 July 2022

In response to the fast-waning immune response and the great threat of the Omicron variant of concern (VOC) to the public, we report the pilot-scale production of an inactivated Omicron vaccine candidate that induces high levels of neutralizing antib...

  • Article
  • Open Access
2 Citations
2,972 Views
9 Pages

19 July 2022

Changes to the national childhood immunization schedule (NCIS) can have a potential impact on vaccine uptake in the community. The NCIS in Singapore has undergone several revisions over the years, with the most recent modification on 1 November 2020....

  • Article
  • Open Access
3 Citations
3,323 Views
13 Pages

Immune Correlates of Disseminated BCG Infection in IL12RB1-Deficient Mice

  • Xuyang Wang,
  • Liqiu Jia,
  • Yang Liu,
  • Jing Wang,
  • Chao Qiu,
  • Tao Li,
  • Wenhong Zhang,
  • Zhaoqin Zhu,
  • Jing Wu and
  • Yanmin Wan

19 July 2022

Interleukin-12 receptor β1 (IL12RB1)-deficient individuals show increased susceptibilities to local or disseminated BCG infection and environmental mycobacteria infection. However, the low clinical penetrance of IL12RB1 deficiency and low recurrence...

  • Article
  • Open Access
28 Citations
4,398 Views
22 Pages

A Recombinant Chimeric Protein-Based Vaccine Containing T-Cell Epitopes from Amastigote Proteins and Combined with Distinct Adjuvants, Induces Immunogenicity and Protection against Leishmania infantum Infection

  • Daniela P. Lage,
  • Danniele L. Vale,
  • Flávia P. Linhares,
  • Camila S. Freitas,
  • Amanda S. Machado,
  • Jamille M. O. Cardoso,
  • Daysiane de Oliveira,
  • Nathália C. Galvani,
  • Marcelo P. de Oliveira and
  • Vívian T. Martins
  • + 11 authors

19 July 2022

Currently, there is no licensed vaccine to protect against human visceral leishmaniasis (VL), a potentially fatal disease caused by infection with Leishmania parasites. In the current study, a recombinant chimeric protein ChimT was developed based on...

  • Brief Report
  • Open Access
2 Citations
2,402 Views
8 Pages

Adults with Trisomy 21 Have Differential Antibody Responses to Influenza A

  • Stephanie James,
  • Robert C. Haight,
  • Cassandra Hanna and
  • Lindsey Furton

19 July 2022

Down syndrome is caused by an extra copy of chromosome 21. In the past two decades, the life expectancy of individuals with Down syndrome has significantly increased from early 20s to early 60s, creating a population of individuals of which little is...

  • Article
  • Open Access
4 Citations
3,473 Views
14 Pages

The Protective Effects of Influenza Vaccination in Elderly Patients with Breast Cancer in Taiwan: A Real-World Evidence-Based Study

  • Szu-Yuan Wu,
  • Ho-Jui Tung,
  • Kuang-Hua Huang,
  • Chiachi Bonnie Lee,
  • Tung-Han Tsai and
  • Yu-Chia Chang

19 July 2022

In elderly patients with newly diagnosed breast cancer, clarity is lacking regarding the effects of influenza vaccines, particularly on clinical outcomes. This study conducted two nationwide, population-based, and propensity score-matched cohorts to...

  • Article
  • Open Access
30 Citations
3,292 Views
9 Pages

Quantitative Analysis of Anti-N and Anti-S Antibody Titers of SARS-CoV-2 Infection after the Third Dose of COVID-19 Vaccination

  • Nuri Lee,
  • Seri Jeong,
  • Su Kyung Lee,
  • Eun-Jung Cho,
  • Jungwon Hyun,
  • Min-Jeong Park,
  • Wonkeun Song and
  • Hyun Soo Kim

18 July 2022

We quantitatively analyzed SARS-CoV-2 antibody levels in patients after two doses of the ChAdOx1 nCoV-19 vaccine and the third BNT162b2 booster. We obtained 255 serum samples from 149 healthcare workers 1 and 4 months after the third dose. Of the 149...

  • Article
  • Open Access
14 Citations
5,135 Views
27 Pages

Development of a T Cell-Based COVID-19 Vaccine Using a Live Attenuated Influenza Vaccine Viral Vector

  • Irina Isakova-Sivak,
  • Ekaterina Stepanova,
  • Victoria Matyushenko,
  • Sergei Niskanen,
  • Daria Mezhenskaya,
  • Ekaterina Bazhenova,
  • Elena Krutikova,
  • Tatiana Kotomina,
  • Polina Prokopenko and
  • Larisa Rudenko
  • + 5 authors

18 July 2022

The COVID-19 pandemic emerged in 2020 and has caused an unprecedented burden to all countries in the world. SARS-CoV-2 continues to circulate and antigenically evolve, enabling multiple reinfections. To address the issue of the virus antigenic variab...

  • Communication
  • Open Access
14 Citations
2,985 Views
6 Pages

Early Clinical Experience with Molnupiravir for Mild to Moderate Breakthrough COVID-19 among Fully Vaccinated Patients at Risk for Disease Progression

  • Antonio Vena,
  • Luca Traman,
  • Martina Bavastro,
  • Alessandro Limongelli,
  • Chiara Dentone,
  • Federica Magnè,
  • Daniele Roberto Giacobbe,
  • Malgorzata Mikulska,
  • Lucia Taramasso and
  • Matteo Bassetti
  • + 1 author

18 July 2022

Information on the efficacy and safety of molnupiravir in daily clinical practice is very scarce. We aimed to describe the clinical characteristics and outcomes of fully vaccinated patients with mild to moderate breakthrough COVID-19 treated with mol...

  • Article
  • Open Access
8 Citations
3,446 Views
10 Pages

Relative Vaccine Effectiveness of the Third Dose of CoronaVac or BNT162b2 Following a Two-Dose CoronaVac Regimen: A Prospective Observational Cohort Study from an Adult Vaccine Center in Turkey

  • Meliha Cagla Sonmezer,
  • Gulcin Telli Dizman,
  • Enes Erul,
  • Taha Koray Sahin,
  • Tuğba Saricaoglu,
  • Alparslan Alp,
  • Mine Durusu Tanriover,
  • Omrum Uzun,
  • Serhat Unal and
  • Murat Akova

18 July 2022

Coronavirus disease 2019 (COVID-19) continues to pose a threat to public health with the potential for the emergence of new variants. Vaccines are the milestones to control and slow down the damage of the pandemic. As of January 2021, a two-dose regi...

  • Article
  • Open Access
9 Citations
3,100 Views
10 Pages

Analysis of Immunization, Adverse Events, and Efficacy of a Fourth Dose of BNT162b2 Vaccine in Health Workers in Mexico, a Pilot Study

  • Maria Elena Romero-Ibarguengoitia,
  • Arnulfo González-Cantú,
  • Diego Rivera-Salinas,
  • Yodira Guadalupe Hernández-Ruíz,
  • Ana Gabriela Armendariz-Vázquez,
  • Irene Antonieta Barco-Flores,
  • Rosalinda González-Facio and
  • Miguel Ángel Sanz-Sánchez

17 July 2022

There is scarce information on seroconversion and adverse events after immunization (AEFI) with the fourth dose of BNT162b2. Our aim was to correlate the magnitude of the antibody response to this vaccination regimen in terms of clinical conditions a...

  • Article
  • Open Access
2 Citations
2,607 Views
10 Pages

The Willingness of the Healthcare Professionals Working in Healthcare Institutions to Accept the First Dose of COVID-19 Vaccine in Jordan: A National Survey

  • Mamdouh El-hneiti,
  • Abeer Shaheen,
  • Malakeh Z. Malak,
  • Rawan Al-Hussami,
  • Sakher Salem Al-Hiary,
  • Mutasem Elfalah and
  • Mahmoud Al-Hussami

17 July 2022

Health workers play an important part as role models, advocates for vaccination, vaccinators and educators in a community. Furthermore, they are at high risk of being infected with COVID-19 as they are on the frontlines. Thus, this study purposed to...

  • Article
  • Open Access
10 Citations
2,947 Views
13 Pages

COVID-19 Outbreak and BNT162b2 mRNA Vaccination Coverage in a Correctional Facility during Circulation of the SARS-CoV-2 Omicron BA.1 Variant in Italy

  • Angela Stufano,
  • Nicola Buonvino,
  • Claudia Maria Trombetta,
  • Daniela Pontrelli,
  • Serena Marchi,
  • Giuseppe Lobefaro,
  • Leonarda De Benedictis,
  • Eleonora Lorusso,
  • Maria Teresa Carofiglio and
  • Piero Lovreglio
  • + 3 authors

17 July 2022

Background. The recent spread of the highly mutated SARS-CoV-2 Omicron variant (B.1.1.529) has raised concerns about protection against COVID-19 in congregate settings such as prisons, characterized by a high risk of transmission and possible difficu...

  • Case Report
  • Open Access
14 Citations
3,149 Views
8 Pages

Two Pediatric Cases of Multisystem Inflammatory Syndrome with Overlapping Neurological Involvement Following SARS-CoV-2 Vaccination and Unknown SARS-CoV2 Infection: The Importance of Pre-Vaccination History

  • Veronica Santilli,
  • Emma Concetta Manno,
  • Carmela Giancotta,
  • Chiara Rossetti,
  • Nicola Cotugno,
  • Donato Amodio,
  • Gioacchino Andrea Rotulo,
  • Annalisa Deodati,
  • Roberto Bianchi and
  • Paolo Palma
  • + 3 authors

16 July 2022

The SARS-CoV-2 vaccine roll-out has been successful around the world. However, there are increasing concerns about adverse events. We report two pediatric cases of Multisystem-Inflammatory-Syndrome (MIS-C) with neurological involvement that occurred...

  • Case Report
  • Open Access
15 Citations
14,044 Views
10 Pages

Clinical and Molecular Characterization of a Rare Case of BNT162b2 mRNA COVID-19 Vaccine-Associated Myositis

  • Eli Magen,
  • Sumit Mukherjee,
  • Mahua Bhattacharya,
  • Rajesh Detroja,
  • Eugene Merzon,
  • Idan Blum,
  • Alejandro Livoff,
  • Mark Shlapobersky,
  • Gideon Baum and
  • Milana Frenkel-Morgenstern
  • + 3 authors

16 July 2022

Initial clinical trials and surveillance data have shown that the most commonly administered BNT162b2 COVID-19 mRNA vaccine is effective and safe. However, several cases of mRNA vaccine-induced mild to moderate adverse events were recently reported....

  • Article
  • Open Access
13 Citations
3,549 Views
18 Pages

Effective Functional Immunogenicity of a DNA Vaccine Combination Delivered via In Vivo Electroporation Targeting Malaria Infection and Transmission

  • Yi Cao,
  • Clifford T. H. Hayashi,
  • Fidel Zavala,
  • Abhai K. Tripathi,
  • Hayk Simonyan,
  • Colin N. Young,
  • Leor C. Clark,
  • Yukari Usuda,
  • Jacob M. Van Parys and
  • Nirbhay Kumar

16 July 2022

Plasmodium falciparum circumsporozoite protein (PfCSP) and Pfs25 are leading candidates for the development of pre-erythrocytic and transmission-blocking vaccines (TBV), respectively. Although considerable progress has been made in developing Pf...

  • Article
  • Open Access
11 Citations
3,844 Views
11 Pages

HPV Vaccination during the COVID-19 Pandemic in Italy: Opportunity Loss or Incremental Cost

  • Francesco Saverio Mennini,
  • Andrea Silenzi,
  • Andrea Marcellusi,
  • Michele Conversano,
  • Andrea Siddu and
  • Giovanni Rezza

16 July 2022

Objectives: Italy was the first European country to introduce universal vaccination of adolescents, for both males and females, against Human Papilloma Virus (HPV) starting in 2017 with the NIP 2017–2019′s release. However, vaccine covera...

  • Case Report
  • Open Access
2 Citations
6,684 Views
6 Pages

Neuromyotonia with Central Nervous System Lesions following Quadrivalent Human Papilloma Virus Vaccination

  • Maryam Hatami,
  • Moritz Förster,
  • Vivien Weyers,
  • Saskia Räuber,
  • Sven G. Meuth and
  • David Kremer

16 July 2022

Neuromyotonia is a rare peripheral nerve hyperexcitability syndrome often associated with antibodies directed against contactin-associated protein-like 2 and leucine-rich, glioma inactivated 1. The quadrivalent human papilloma virus vaccine Gardasil&...

  • Article
  • Open Access
3 Citations
3,886 Views
22 Pages

SARS-CoV-2 Antibody Response against Mild-to-Moderate Breakthrough COVID-19 in Home Isolation Setting in Thailand

  • Pichanun Mongkolsucharitkul,
  • Apinya Surawit,
  • Sureeporn Pumeiam,
  • Nitat Sookrung,
  • Anchalee Tungtrongchitr,
  • Pochamana Phisalprapa,
  • Naruemit Sayabovorn,
  • Weerachai Srivanichakorn,
  • Chaiwat Washirasaksiri and
  • on behalf of the Siriraj Population Health and Nutrition Research (SPHERE) Group
  • + 11 authors

15 July 2022

Background: In December 2021, Omicron replaced Delta as the dominant coronavirus disease 2019 (COVID-19) variant in Thailand. Both variants embody diverse epidemiological trends and immunogenicity. We investigated whether Delta and Omicron patients’...

  • Article
  • Open Access
8 Citations
2,959 Views
11 Pages

Immune Response after mRNA COVID-19 Vaccination in Lung Transplant Recipients: A 6-Month Follow-Up

  • Selma Tobudic,
  • Alberto Benazzo,
  • Maximilian Koblischke,
  • Lisa Schneider,
  • Stephan Blüml,
  • Florian Winkler,
  • Hannah Schmidt,
  • Stefan Vorlen,
  • Helmuth Haslacher and
  • Stefan Winkler
  • + 4 authors

15 July 2022

Background and objective: This prospective cohort study analyzed the immune response to COVID-19 mRNA vaccines in lung transplant recipients (LuTRs) compared to healthy controls (HCs) at a 6-month follow-up. Methods: After the first two doses of eith...

  • Article
  • Open Access
9 Citations
3,036 Views
12 Pages

Predictors of COVID-19 Vaccine Intention: Evidence from Chile, Mexico, and Colombia

  • Camila Salazar-Fernández,
  • María José Baeza-Rivera,
  • Marcoantonio Villanueva,
  • Joaquín Alberto Padilla Bautista,
  • Regina M. Navarro and
  • Mariana Pino

15 July 2022

(1) Background: Although the evidence is consistent that vaccines for COVID-19 effectively prevent severe illness or death, the rapid development of vaccines has led to increased beliefs about possible negative consequences and conspiracy theories ab...

  • Case Report
  • Open Access
5 Citations
3,113 Views
5 Pages

15 July 2022

A considerable number of travelers receive multiple travel vaccinations before going on holiday. Here, we present a case report of a 56-year-old male traveler. On day 1, he received vaccinations against influenza, Tdab (tetanus toxoid, reduced diphth...

  • Article
  • Open Access
10 Citations
4,006 Views
24 Pages

An In-Silico Investigation to Design a Multi-Epitopes Vaccine against Multi-Drug Resistant Hafnia alvei

  • Fahad M. Alshabrmi,
  • Faris Alrumaihi,
  • Sahar Falah Alrasheedi,
  • Wafa Abdullah I. Al-Megrin,
  • Ahmad Almatroudi and
  • Khaled S. Allemailem

15 July 2022

Antimicrobial resistance has become a significant health issue because of the misuse of antibiotics in our daily lives, resulting in high rates of morbidity and mortality. Hafnia alvei is a rod-shaped, Gram-negative and facultative anaerobic bacteria...

  • Article
  • Open Access
10 Citations
3,542 Views
13 Pages

Motivators and Barriers to HPV Vaccination: A Qualitative Study of Underserved Women Attending Planned Parenthood

  • Emilia J. Fields,
  • Suellen Hopfer,
  • Jennifer R. Warren,
  • Rhonda BeLue,
  • Joel Lebed and
  • Michael L. Hecht

15 July 2022

Human papilloma virus (HPV) is the most common sexually transmitted infection in the United States. Disease-associated strains of HPV can cause genital warts and six cancer types. HPV-associated cervical cancer disproportionately impacts medically un...

  • Article
  • Open Access
8 Citations
3,348 Views
14 Pages

Assessment of Clinical Profile and Treatment Outcome in Vaccinated and Unvaccinated SARS-CoV-2 Infected Patients

  • Ganesh Korishettar,
  • Prashanth Chikkahonnaiah,
  • SubbaRao V. Tulimilli,
  • Siva Dallavalasa,
  • Shashidhar H. Byrappa,
  • SubbaRao V. Madhunapantula and
  • Ravindra P. Veeranna

15 July 2022

Vaccines against severe acute respiratory syndrome-corona virus-2 (SARS-CoV-2) infection, which causes coronavirus disease–19 (COVID-19) in humans, have been developed and are being tested for safety and efficacy. We conducted the cross-section...

  • Review
  • Open Access
13 Citations
5,505 Views
27 Pages

Nanoparticle- and Microparticle-Based Vaccines against Orbiviruses of Veterinary Importance

  • Luis Jiménez-Cabello,
  • Sergio Utrilla-Trigo,
  • Natalia Barreiro-Piñeiro,
  • Tomás Pose-Boirazian,
  • José Martínez-Costas,
  • Alejandro Marín-López and
  • Javier Ortego

14 July 2022

Bluetongue virus (BTV) and African horse sickness virus (AHSV) are widespread arboviruses that cause important economic losses in the livestock and equine industries, respectively. In addition to these, another arthropod-transmitted orbivirus known a...

  • Article
  • Open Access
5 Citations
2,759 Views
16 Pages

The T Cell Epitope Landscape of SARS-CoV-2 Variants of Concern

  • Simen Tennøe,
  • Marius Gheorghe,
  • Richard Stratford and
  • Trevor Clancy

14 July 2022

During the COVID-19 pandemic, several SARS-CoV-2 variants of concern (VOC) emerged, bringing with them varying degrees of health and socioeconomic burdens. In particular, the Omicron VOC displayed distinct features of increased transmissibility accom...

  • Article
  • Open Access
23 Citations
3,619 Views
11 Pages

Association between Recent Usage of Antibiotics and Immunogenicity within Six Months after COVID-19 Vaccination

  • Ka-Shing Cheung,
  • Lok-Ka Lam,
  • Ruiqi Zhang,
  • Poh-Hwa Ooi,
  • Jing-Tong Tan,
  • Wai-Pan To,
  • Chun-Him Hui,
  • Kwok-Hung Chan,
  • Wai-Kay Seto and
  • Wai K. Leung
  • + 1 author

14 July 2022

Background: Gut microbiota can be associated with COVID-19 vaccine immunogenicity. We investigated whether recent antibiotic use influences BNT162b2 vaccine immunogenicity. Methods: BNT162b2 recipients from three centers were prospectively recruited....

  • Communication
  • Open Access
5 Citations
2,541 Views
6 Pages

Racial Disparities in Hepatitis B Birth Dose in the Washington Metropolitan Region, 2018–2020

  • Hee-Soon Juon,
  • Donna T. Sheler,
  • Jane Pan,
  • Daisy Le and
  • Y. Tony Yang

14 July 2022

Hepatitis B vaccination protects newborns from contracting the hepatitis B virus that may lead to chronic infection, liver failure, or death. Trends and racial differences in the administration of the hepatitis B (HepB) birth dose in 2018–2020...

  • Review
  • Open Access
13 Citations
4,644 Views
12 Pages

The Big Potential of Small Particles: Lipid-Based Nanoparticles and Exosomes in Vaccination

  • Marina Ben Shimon,
  • Shiran Shapira,
  • Jonathan Seni and
  • Nadir Arber

13 July 2022

Some of the most significant medical achievements in recent history are the development of distinct and effective vaccines, and the improvement of the efficacy of previously existing ones, which have contributed to the eradication of many dangerous a...

  • Review
  • Open Access
88 Citations
15,227 Views
62 Pages

Advances in Infectious Disease Vaccine Adjuvants

  • Jingyi Fan,
  • Shengbin Jin,
  • Lachlan Gilmartin,
  • Istvan Toth,
  • Waleed M. Hussein and
  • Rachel J. Stephenson

13 July 2022

Vaccines are one of the most significant medical interventions in the fight against infectious diseases. Since their discovery by Edward Jenner in 1796, vaccines have reduced the worldwide transmission to eradication levels of infectious diseases, in...

  • Article
  • Open Access
36 Citations
5,070 Views
13 Pages

Vaccine Resistance and Hesitancy among Older Adults Who Live Alone or Only with an Older Partner in Community in the Early Stage of the Fifth Wave of COVID-19 in Hong Kong

  • Dexing Zhang,
  • Weiju Zhou,
  • Paul Kwok-Ming Poon,
  • Kin On Kwok,
  • Tracy Wai-Sze Chui,
  • Phoebe Hoi Yi Hung,
  • Bonny Yin Tung Ting,
  • Dicken Cheong-Chun Chan and
  • Samuel Yeung-Shan Wong

13 July 2022

Vaccination is an effective way in providing protection against COVID-19 infection and severe outcomes. However, vaccine resistance and hesitancy are a great concern among vulnerable populations including older adults who live alone or only with an o...

  • Article
  • Open Access
8 Citations
2,931 Views
13 Pages

Specific T-Cell Immune Response to SARS-CoV-2 Spike Protein over Time in Naïve and SARS-CoV-2 Previously Infected Subjects Vaccinated with BTN162b2

  • Natali Vega-Magaña,
  • José Francisco Muñoz-Valle,
  • Marcela Peña-Rodríguez,
  • Oliver Viera-Segura,
  • Ana Laura Pereira-Suárez,
  • Jorge Hernández-Bello and
  • Mariel García-Chagollan

13 July 2022

Due to the COVID-19 pandemic, the rapid development of vaccines against SARS-CoV-2 has been promoted. BNT162b2 is a lipid-nanoparticle mRNA vaccine with 95% efficacy and is the most administered vaccine globally. Nevertheless, little is known about t...

  • Article
  • Open Access
18 Citations
3,966 Views
14 Pages

COVID-19 Vaccine Coverage and Potential Drivers of Vaccine Uptake among Healthcare Workers in SOMALIA: A Cross-Sectional Study

  • Hassan Abdullahi Dahie,
  • Jamal Hassan Mohamoud,
  • Mohamed Hussein Adam,
  • Bashiru Garba,
  • Najib Isse Dirie,
  • Maryan Abdullahi Sh. Nur and
  • Fartun Yasin Mohamed

13 July 2022

Healthcare workers (HCWs) are one of the most vulnerable groups for contracting COVID-19 and dying as a result of it. Over 10,000 HCWs in Africa have been infected with COVID-19, according to the World Health Organization, making it a substantial occ...

  • Article
  • Open Access
11 Citations
16,825 Views
12 Pages

Risk Factors and Incidence Rates of Self-Reported Short-Term Adverse Events of COVID-19 Vaccine Booster Dose

  • Po-Yu Chen,
  • Bih-Ju Wu,
  • Mei-Chin Su,
  • Yen-Hsi Lin,
  • Shu-Chiung Chiang,
  • Jau-Ching Wu,
  • Tzeng-Ji Chen and
  • Yu-Chun Chen

13 July 2022

With the spread of the new SARS-CoV-2 variants, many countries have begun COVID-19 vaccine booster programs with the mix-and-match strategy. However, research on the adverse events (AE) of booster doses is still scarce. The aim of our study was to an...

of 4

Get Alerted

Add your email address to receive forthcoming issues of this journal.

XFacebookLinkedIn
Vaccines - ISSN 2076-393X